RxGen is a specialty translational research company devoted to understanding and overcoming human disease through innovative preclinical modeling. We apply significant preclinical and therapeutic domain expertise in ophthalmic, central nervous system, cardiovascular and metabolic disease to develop and apply translational models to meet the scientific needs of the global biomedical research community.
The RxGen Platform
From discovery to development to post-market repositioning, RxGen has established a powerful preclinical platform to provide critical insight into the safety and efficacy of novel therapies, medical devices and delivery technologies to accelerate and strengthen the path to clinic and associated development decisions. RxGen has advanced discovery and development programs for a wide range of requirements in the pharmaceutical and biotechnology industries. We place ultimate value on scientific excellence and innovation and the effectiveness with which our resources and models are applied toward achieving objectives.
RxGen’s Research Programs
We maintain active research and development programs related to the characterization and validation of new translational research models and technologies that can reduce risk and drive further efficiencies in the drug discovery and development process. This is achieved by harnessing significant therapeutic domain expertise, robust study design and data analysis, and state of the art instrumentation and endpoints, coupled with our unique primate research resources.
- Our Engagement Model – RxGen offers several engagement models, from contract research studies and research collaborations to R&D partnering and platform access agreements with dedicated research teams aligned to efficiently advance discovery and development objectives.
- Efficacy Assessments – Leveraging our portfolio of models and associated preclinical capabilities, RxGen designs and conducts efficacy studies of small molecules, biologics, cell and gene therapies and medical devices.
- Pharmacokinetics, Pharmacodynamics and Delivery Optimization – RxGen conducts rapid turnaround PK and PD studies in drug naïve or non-naïve subjects of preferred age, sex, weight and number with performance of bioanalytics through a preferred provider or secure sample shipment to study sponsors.
- Facilities & Infrastructure – RxGen’s research facilities have been designed to optimize animal wellbeing and study outcomes and we are recognized for our commitment to each.